Form 8-K - Current report:
SEC Accession No. 0001437749-21-018751
Filing Date
2021-08-05
Accepted
2021-08-05 16:08:33
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20210804_8k.htm   iXBRL 8-K 30028
2 EXHIBIT 99.1 ex_271963.htm EX-99.1 94454
7 ex_271963img001.jpg GRAPHIC 3532
  Complete submission text file 0001437749-21-018751.txt   274360

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210805.xsd EX-101.SCH 3700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210805_def.xml EX-101.DEF 11585
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210805_lab.xml EX-101.LAB 15465
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210805_pre.xml EX-101.PRE 11739
8 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210804_8k_htm.xml XML 2582
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 211148203
SIC: 2836 Biological Products, (No Diagnostic Substances)